Search Results 961-970 of 21415 for anti-TNF drugs

1. Atropine, Hyoscyamine, Methenamine, Methylene Blue, Phenyl Salicylate, And Benzoic Acid (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

2. Decongestant And Analgesic Combinations (Oral Route) Before Using - Mayo Clinic

   Allergies. Tell your doctor if you have ever had any unusual or allergic reaction to medicines in this group or any other medicines. Also tell your health care ...

3. Dihydroergotamine (Injection Route) Before Using - Mayo Clinic

   An alternative to this medication should be prescribed or you should stop breastfeeding while using this medicine. Drug Interactions. Although certain medicines ...

4. Levonorgestrel And Ethinyl Estradiol (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

5. Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer - Mayo Clinic

   ... TNF] agents) within 4 weeks prior to cycle 1, day ... drugs); replacement therapy ... A stable regimen of highly active anti-retroviral therapy (HAART) ...

6. Chlorthalidone (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

7. Antiphospholipid syndrome - Symptoms & causes - Mayo Clinic

   Learn about causes and treatment of this blood disorder that mainly affects women and may cause blood clots and miscarriages.

8. Dextroamphetamine (Transdermal Route) Description and Brand Names - Mayo Clinic

   Dextroamphetamine transdermal patch is used to treat attention-deficit hyperactivity disorder (ADHD). It belongs to the group of medicines called central ...

9. A Study to Assess the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic Treatment - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name ... Subject who received IV anti-infectives within 35 days prior to ...

10. PCSK9 inhibition: A game changer in cholesterol management - Mayo Clinic

    ... anti-PCSK9 drugs. The mechanisms by which PCSK9 inhibitors decrease levels of lipoprotein(a) are unknown at present. Two simultaneously published studies ...